세계의 멀티플렉스 어세이 시장 보고서(2025년)

Multiplex assays are employed to amplify multiple targets in a polymerase chain reaction (PCR) trial, enabling the extraction of additional information from minuscule amounts of proteins or other analyses in a shorter time compared to traditional systems, similar to ELISA. These assays find application in pathogen identification, mutation analysis, RNA discovery, gene discovery analysis, relation analysis, forensic studies, and other scientific endeavors.

The primary types of multiplex assays comprise nucleic acid-based multiplex assays, protein-based multiplex assays, and others. Nucleic acid-based multiplex assays rely on nucleic acids to detect organism-specific DNA or RNA sequences. These tests are generally characterized by specificity and high sensitivity, providing rapid results. Various technologies underpin multiplex assays, including flow cytometry, luminescence, fluorescence detection, multiplex real-time PCR, and other related technologies. Multiplex assays serve diverse applications, including research and development, as well as clinical diagnostics. End-users encompass pharmaceutical and biotechnology companies, hospitals and research institutes, reference laboratories, and other entities involved in scientific research and diagnostics.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The multiplex assays market research report is one of a series of new reports from The Business Research Company that provides multiplex assays market statistics, including multiplex assays industry global market size, regional shares, competitors with multiplex assays market share, detailed multiplex assays market segments, market trends and opportunities, and any further data you may need to thrive in the multiplex assays industry. This multiplex assays market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The multiplex assays market size has grown strongly in recent years. It will grow from $3.67 billion in 2024 to $3.88 billion in 2025 at a compound annual growth rate (CAGR) of 6.0%. The growth in the historic period can be attributed to increased healthcare expenditure, emerging markets growth, rapid technological advances, and a rapid growth in the aging population.

The multiplex assays market size is expected to see strong growth in the next few years. It will grow to $5.33 billion in 2029 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to the rise in funding, government initiatives for genetic and microbiological research, aging population, increasing prevalence of chronic diseases and a rapid rise in various bacterial and viral epidemics. Major trends in the forecast period include the rise in funding, government initiatives for genetic and microbiological research, the aging population, the increasing prevalence of chronic diseases, and a rapid rise in various bacterial and viral epidemics.

The forecast of 8.2% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. adoption of high-throughput diagnostics by inflating prices of multiplex immunoassay platforms and reagent panels developed in Japan and South Korea, resulting in slower biomarker analysis and higher clinical lab costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing incidence of chronic diseases is fueling growth in the global multiplex assay market. Multiplex assays are widely used in clinical trials to assess disease efficacy and to detect antibodies related to various conditions. For instance, in September 2023, a report by the World Health Organization (WHO) highlighted that chronic diseases, also known as non-communicable diseases (NCDs), are responsible for 74% of global deaths, amounting to 41 million fatalities annually. Consequently, the growing prevalence of chronic diseases is expected to drive demand in the global multiplex assay market.

The market for multiplex assays is expected to be further driven by increased funding from governments and private organizations. Significant investments are being made to develop multiplex assays, especially amid the challenges posed by the COVID-19 pandemic. The surge in COVID-19 testing has led to consolidation and merger activities. For instance, in May 2024, Autonomous Medical Devices Incorporated (AMDI), a U.S.-based biotechnology company, received a $5.2 million grant from the National Institutes of Health (NIH) to finalize its rapid point-of-care (POC) viral testing system. This system employs polymerase chain reaction (PCR), a highly regarded method for amplifying specific DNA sequences, enabling accurate detection of viral genetic material. With its capability to identify even minimal amounts of viral RNA or DNA, the system offers high sensitivity and specificity, making it a valuable tool for diagnosing infections at their early stages.

Companies in the market are actively launching innovative tests based on multiplex assays to fortify their market positions. In May 2022, QuantuMDx Group Limited introduced the Q-POC SARS-CoV-2, Flu A/B, and RSV Assay, a multiplex panel designed to detect SARS-CoV-2, Influenza A, Influenza B, and RSV at the point of need, further showcasing the market's evolution.

Companies in the multiplex assay market are prioritizing new product launches to enhance their market presence. For example, in January 2024, Bio-Rad Laboratories Inc., a U.S.-based company specializing in life science research and clinical diagnostic products, introduced the ddPLEX ESR1 Mutation Detection Kit. This kit is the first ultrasensitive multiplexed digital PCR assay designed specifically for detecting breast cancer mutations in clinical research. It allows for the simultaneous detection and quantification of seven relevant ESR1 mutations in a single well, simplifying the testing process. With an analytical sensitivity of 0.01% variant allele fraction (VAF), it can detect low-frequency mutations, which are crucial in cancer diagnostics. Additionally, the kit is compatible with circulating tumor DNA (ctDNA) from plasma and DNA from formalin-fixed paraffin-embedded (FFPE) tissue samples, offering flexibility in sample types for testing.

In May 2022, CellCarta, a Canada-based precision laboratory services company, acquired Precision Assays for an undisclosed amount. This acquisition aims to expand CellCarta's precision medicine laboratory services by obtaining commercial rights to antibody panels and assays developed by Precision Assays. Through this acquisition, CellCarta enhances its capabilities in next-generation targeted proteomics testing solutions, especially benefiting its pharmaceutical and biotech clients. Precision Assays, a U.S.-based developer, specializes in high-end multiplex quantitative immuno-MRM mass spectrometry-based assays, adding advanced analytical capabilities to CellCarta's service offerings.

Major companies operating in the multiplex assays market include Seegene Inc, DiaSorin SpA, Thermo Fisher Scientific Inc, Bio-Rad Laboratories Inc, Abcam Plc, PerkinElmer Inc, Hologic Corporation, Meso Scale Diagnostics, Merck KGaA, Roche Diagnostics India Pvt Ltd, bioMerieux India, Becton Dickinson Private Limited, Danaher Corporation, Johnson & Johnson, Simens Healthcare, Beckman Coulter Inc. India, Ortho Clinical Diagnostics, Sysmex Corporation, Siemens Healthineers Ukraine, TestLine Clinical Diagnostics s.r.o., Cepheid, F. Hoffmann-La Roche Ltd., Hologic, Bayer AG, Cantel Medical Corporation, Meridian Bioscience, Faizyme Laboratories, Alere Inc., Bangs Laboratories Inc, The Merck Group, Takara Bio Inc, Qiagen, Spherotech Inc, Geneaid Biotech Ltd, Rockland Immunochemicals Inc, GenScript Biotech Corporation

North America was the largest region in the multiplex assays market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the multiplex assays market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the multiplex assays market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The multiplex assays market consists of sales of equipment with technologies that can detect multiple genes such as flow cytometry, fluorescence detection, luminescence, multiplex real-time PCR, and other technologies in multiplex assays. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Multiplex Assays Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on multiplex assays market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for multiplex assays ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The multiplex assays market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Protein-Based Multiplex Assays, Nucleic Acid-Based Multiplex Assays, Other Types
• 2) By Identification Technology: Flow Cytometry, Multiplex Real-Time PCR, Other Identification Technologies
• 3) By Detection Technology: Enzyme-Linked Immunosorbent Assay (ELISA), Luminescence, Fluorescence, Other Detection Technologies
• 4) By Application: Research And Development, Clinical Diagnostics
• 5) By End User: Pharmaceutical And Biotechnology Companies, Hospitals And Research Institutes, Reference Laboratories, Other End-Users
• Subsegments:
• 1) By Protein-Based Multiplex Assays: ELISA (Enzyme-Linked Immunosorbent Assay); Luminex xMAP Technology; Western Blotting; Immunohistochemistry; Mass Spectrometry-Based Assays
• 2) By Nucleic Acid-Based Multiplex Assays: PCR (Polymerase Chain Reaction); qPCR (Quantitative PCR); NGS (Next-Generation Sequencing); Microarray Analysis; RT-PCR (Reverse Transcription PCR)
• 3) By Other Types: Cell-Based Multiplex Assays; Bioanalytical Assays; Imaging-Based Assays; Surface Plasmon Resonance (SPR) Assays
• Companies Mentioned: Seegene Inc; DiaSorin SpA; Thermo Fisher Scientific Inc; Bio-Rad Laboratories Inc; Abcam Plc; PerkinElmer Inc; Hologic Corporation; Meso Scale Diagnostics; Merck KGaA; Roche Diagnostics India Pvt Ltd; bioMerieux India; Becton Dickinson Private Limited; Danaher Corporation; Johnson & Johnson; Simens Healthcare; Beckman Coulter Inc. India; Ortho Clinical Diagnostics; Sysmex Corporation; Siemens Healthineers Ukraine; TestLine Clinical Diagnostics s.r.o.; Cepheid; F. Hoffmann-La Roche Ltd.; Hologic; Bayer AG; Cantel Medical Corporation; Meridian Bioscience; Faizyme Laboratories; Alere Inc.; Bangs Laboratories Inc; The Merck Group; Takara Bio Inc; Qiagen; Spherotech Inc; Geneaid Biotech Ltd; Rockland Immunochemicals Inc; GenScript Biotech Corporation
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Multiplex Assays Market Characteristics

3. Multiplex Assays Market Trends And Strategies

4. Multiplex Assays Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Multiplex Assays Growth Analysis And Strategic Analysis Framework

• 5.1. Global Multiplex Assays PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Multiplex Assays Market Growth Rate Analysis
• 5.4. Global Multiplex Assays Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Multiplex Assays Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Multiplex Assays Total Addressable Market (TAM)

6. Multiplex Assays Market Segmentation

• 6.1. Global Multiplex Assays Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Protein-Based Multiplex Assays
• Nucleic Acid-Based Multiplex Assays
• Other Types
• 6.2. Global Multiplex Assays Market, Segmentation By Identification Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Flow Cytometry
• Multiplex Real-Time PCR
• Other Identification Technologies
• 6.3. Global Multiplex Assays Market, Segmentation By Detection Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Enzyme-Linked Immunosorbent Assay (ELISA)
• Luminescence
• Fluorescence
• Other Detection Technologies
• 6.4. Global Multiplex Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Research And Development
• Clinical Diagnostics
• 6.5. Global Multiplex Assays Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmaceutical And Biotechnology Companies
• Hospitals And Research Institutes
• Reference Laboratories
• Other End-Users
• 6.6. Global Multiplex Assays Market, Sub-Segmentation Of Protein-Based Multiplex Assays, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• ELISA (Enzyme-Linked Immunosorbent Assay)
• Luminex xMAP Technology
• Western Blotting
• Immunohistochemistry
• Mass Spectrometry-Based Assays
• 6.7. Global Multiplex Assays Market, Sub-Segmentation Of Nucleic Acid-Based Multiplex Assays, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• PCR (Polymerase Chain Reaction)
• qPCR (Quantitative PCR)
• NGS (Next-Generation Sequencing)
• Microarray Analysis
• RT-PCR (Reverse Transcription PCR)
• 6.8. Global Multiplex Assays Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cell-Based Multiplex Assays
• Bioanalytical Assays
• Imaging-Based Assays
• Surface Plasmon Resonance (SPR) Assays

7. Multiplex Assays Market Regional And Country Analysis

• 7.1. Global Multiplex Assays Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Multiplex Assays Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Multiplex Assays Market

• 8.1. Asia-Pacific Multiplex Assays Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Multiplex Assays Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Multiplex Assays Market, Segmentation By Identification Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Multiplex Assays Market, Segmentation By Detection Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Multiplex Assays Market

• 9.1. China Multiplex Assays Market Overview
• 9.2. China Multiplex Assays Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Multiplex Assays Market, Segmentation By Identification Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Multiplex Assays Market, Segmentation By Detection Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Multiplex Assays Market

• 10.1. India Multiplex Assays Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Multiplex Assays Market, Segmentation By Identification Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Multiplex Assays Market, Segmentation By Detection Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Multiplex Assays Market

• 11.1. Japan Multiplex Assays Market Overview
• 11.2. Japan Multiplex Assays Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Multiplex Assays Market, Segmentation By Identification Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Multiplex Assays Market, Segmentation By Detection Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Multiplex Assays Market

• 12.1. Australia Multiplex Assays Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Multiplex Assays Market, Segmentation By Identification Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Multiplex Assays Market, Segmentation By Detection Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Multiplex Assays Market

• 13.1. Indonesia Multiplex Assays Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Multiplex Assays Market, Segmentation By Identification Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Multiplex Assays Market, Segmentation By Detection Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Multiplex Assays Market

• 14.1. South Korea Multiplex Assays Market Overview
• 14.2. South Korea Multiplex Assays Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Multiplex Assays Market, Segmentation By Identification Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Multiplex Assays Market, Segmentation By Detection Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Multiplex Assays Market

• 15.1. Western Europe Multiplex Assays Market Overview
• 15.2. Western Europe Multiplex Assays Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Multiplex Assays Market, Segmentation By Identification Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Multiplex Assays Market, Segmentation By Detection Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Multiplex Assays Market

• 16.1. UK Multiplex Assays Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Multiplex Assays Market, Segmentation By Identification Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Multiplex Assays Market, Segmentation By Detection Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Multiplex Assays Market

• 17.1. Germany Multiplex Assays Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Multiplex Assays Market, Segmentation By Identification Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Multiplex Assays Market, Segmentation By Detection Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Multiplex Assays Market

• 18.1. France Multiplex Assays Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Multiplex Assays Market, Segmentation By Identification Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Multiplex Assays Market, Segmentation By Detection Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Multiplex Assays Market

• 19.1. Italy Multiplex Assays Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Multiplex Assays Market, Segmentation By Identification Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Multiplex Assays Market, Segmentation By Detection Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Multiplex Assays Market

• 20.1. Spain Multiplex Assays Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Multiplex Assays Market, Segmentation By Identification Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Multiplex Assays Market, Segmentation By Detection Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Multiplex Assays Market

• 21.1. Eastern Europe Multiplex Assays Market Overview
• 21.2. Eastern Europe Multiplex Assays Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Multiplex Assays Market, Segmentation By Identification Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Multiplex Assays Market, Segmentation By Detection Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Multiplex Assays Market

• 22.1. Russia Multiplex Assays Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Multiplex Assays Market, Segmentation By Identification Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Multiplex Assays Market, Segmentation By Detection Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Multiplex Assays Market

• 23.1. North America Multiplex Assays Market Overview
• 23.2. North America Multiplex Assays Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Multiplex Assays Market, Segmentation By Identification Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Multiplex Assays Market, Segmentation By Detection Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Multiplex Assays Market

• 24.1. USA Multiplex Assays Market Overview
• 24.2. USA Multiplex Assays Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Multiplex Assays Market, Segmentation By Identification Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Multiplex Assays Market, Segmentation By Detection Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Multiplex Assays Market

• 25.1. Canada Multiplex Assays Market Overview
• 25.2. Canada Multiplex Assays Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Multiplex Assays Market, Segmentation By Identification Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Multiplex Assays Market, Segmentation By Detection Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Multiplex Assays Market

• 26.1. South America Multiplex Assays Market Overview
• 26.2. South America Multiplex Assays Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Multiplex Assays Market, Segmentation By Identification Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Multiplex Assays Market, Segmentation By Detection Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Multiplex Assays Market

• 27.1. Brazil Multiplex Assays Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Multiplex Assays Market, Segmentation By Identification Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Multiplex Assays Market, Segmentation By Detection Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Multiplex Assays Market

• 28.1. Middle East Multiplex Assays Market Overview
• 28.2. Middle East Multiplex Assays Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Multiplex Assays Market, Segmentation By Identification Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Multiplex Assays Market, Segmentation By Detection Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Multiplex Assays Market

• 29.1. Africa Multiplex Assays Market Overview
• 29.2. Africa Multiplex Assays Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Multiplex Assays Market, Segmentation By Identification Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Multiplex Assays Market, Segmentation By Detection Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Multiplex Assays Market Competitive Landscape And Company Profiles

• 30.1. Multiplex Assays Market Competitive Landscape
• 30.2. Multiplex Assays Market Company Profiles
  • 30.2.1. Seegene Inc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. DiaSorin SpA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Thermo Fisher Scientific Inc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Bio-Rad Laboratories Inc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Abcam Plc Overview, Products and Services, Strategy and Financial Analysis

31. Multiplex Assays Market Other Major And Innovative Companies

• 31.1. PerkinElmer Inc
• 31.2. Hologic Corporation
• 31.3. Meso Scale Diagnostics
• 31.4. Merck KGaA
• 31.5. Roche Diagnostics India Pvt Ltd
• 31.6. bioMerieux India
• 31.7. Becton Dickinson Private Limited
• 31.8. Danaher Corporation
• 31.9. Johnson & Johnson
• 31.10. Simens Healthcare
• 31.11. Beckman Coulter Inc. India
• 31.12. Ortho Clinical Diagnostics
• 31.13. Sysmex Corporation
• 31.14. Siemens Healthineers Ukraine
• 31.15. TestLine Clinical Diagnostics s.r.o.

32. Global Multiplex Assays Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Multiplex Assays Market

34. Recent Developments In The Multiplex Assays Market

35. Multiplex Assays Market High Potential Countries, Segments and Strategies

• 35.1 Multiplex Assays Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Multiplex Assays Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Multiplex Assays Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer